Hennion & Walsh Asset Management’s Editas Medicine EDIT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-263,069	Closed	-$650K	–	974
2026 Q1	$650K	Sell	263,069 -16,465	-6%	-$34.8K	0.02%	631
2025 Q4	$573K	Buy	279,534 +37,843	+16%	+$109K	0.02%	675
2025 Q3	$839K	Sell	241,691 -4,401	-2%	-$12.3K	0.03%	556
2025 Q2	$541K	Sell	246,092 -11,368	-4%	-$18.6K	0.02%	644
2025 Q1	$299K	Sell	257,460 -10,298	-4%	-$15.1K	0.01%	762
2024 Q4	$340K	Buy	267,758 +41,002	+18%	+$104K	0.02%	730
2024 Q3	$773K	Buy	226,756 +58,385	+35%	+$254K	0.04%	512
2024 Q2	$786K	Buy	+168,371	New	+$950K	0.04%	481

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Hennion & Walsh Asset Management's EDIT Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 263,069 shares — an estimated $650K sold.

Hennion & Walsh Asset Management first reported a position in EDIT in Q2 2024 and held it in 8 quarters. The position peaked at $839K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Hennion & Walsh Asset Management reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
Hennion & Walsh Asset Management sold 263,069 Editas Medicine shares in Q2 2026, an estimated $650K.
Hennion & Walsh Asset Management first reported a position in Editas Medicine in Q2 2024 and held it in 8 quarters.
Hennion & Walsh Asset Management's Editas Medicine position peaked at $839K in Q3 2025.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.